Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02185 (Long intergenic non-protein coding RNA 2185) is a gene encoding a long intergenic non-coding RNA (lincRNA) in humans[1]. LincRNAs are genomic regions that transcribe long RNA molecules (>200 nucleotides) without protein-coding potential and typically do not overlap protein-coding genes[3]. They generally participate in the regulation of gene expression, chromatin remodeling, and may have tissue-specific regulatory roles[3]. However, there is no specific literature reporting functional biological roles, molecular mechanisms, disease associations, or clinical relevance for LINC02185 itself as of the current knowledge base and search results, including authoritative sources such as GeneCards[1]. This distinguishes it from other lincRNAs (such as LINC00665), which have defined functional and disease roles[2]. Therefore, LINC02185 is not currently recognized as a therapeutic target, clinical biomarker, or druggable entity. Notes on correctness: Although LINC02185 is a legitimate non-coding RNA gene annotated in genomic databases[1], there is no evidence in the literature that this gene is a therapeutic target or functionally characterized molecule as defined by major molecular target classification schemas. If the intention was to refer to a characterized lincRNA, another gene (such as LINC00665) might be relevant; please verify the context or spelling if specific disease association or drug targeting information is needed. Summary of limitations: - No functional data, disease link, or therapeutic targeting information specific to LINC02185 available[1]. - Classification as "target" is not supported without additional evidence. - Information reflects the state as of September 2025 and may change with future research.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2185 (LINC02185).